CME Group Inc.
CME · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $6,130,100 | $5,578,900 | $5,019,400 | $4,689,700 |
| % Growth | 9.9% | 11.1% | 7% | – |
| Cost of Goods Sold | $850,300 | $828,600 | $753,100 | $837,000 |
| Gross Profit | $5,279,800 | $4,750,300 | $4,266,300 | $3,852,700 |
| % Margin | 86.1% | 85.1% | 85% | 82.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $132,700 | $144,400 | $137,400 | $151,700 |
| SG&A Expenses | $132,700 | $144,400 | $137,400 | $151,700 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $1,215,600 | $1,170,200 | $1,113,000 | $1,055,800 |
| Operating Expenses | $1,348,300 | $1,314,600 | $1,250,400 | $1,207,500 |
| Operating Income | $3,931,500 | $3,435,700 | $3,015,900 | $2,645,200 |
| % Margin | 64.1% | 61.6% | 60.1% | 56.4% |
| Other Income/Exp. Net | $609,900 | $717,900 | $474,400 | $728,400 |
| Pre-Tax Income | $4,541,400 | $4,153,600 | $3,490,300 | $3,373,600 |
| Tax Expense | $1,015,600 | $927,400 | $799,300 | $736,700 |
| Net Income | $3,525,800 | $3,226,200 | $2,691,000 | $2,636,400 |
| % Margin | 57.5% | 57.8% | 53.6% | 56.2% |
| EPS | 9.69 | 8.87 | 7.41 | 7.3 |
| % Growth | 9.2% | 19.7% | 1.5% | – |
| EPS Diluted | 9.67 | 8.86 | 7.4 | 7.29 |
| Weighted Avg Shares Out | 359,389 | 359,023 | 358,713 | 358,340 |
| Weighted Avg Shares Out Dil | 359,944 | 359,500 | 359,181 | 358,929 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $160,900 | $159,400 | $162,700 | $166,900 |
| Depreciation & Amortization | $336,800 | $352,600 | $362,600 | $385,400 |
| EBITDA | $5,039,100 | $4,665,600 | $4,015,600 | $3,925,900 |
| % Margin | 82.2% | 83.6% | 80% | 83.7% |